177 related articles for article (PubMed ID: 25514412)
1. Expression of the MT1 melatonin receptor in ovarian cancer cells.
Jablonska K; Pula B; Zemla A; Kobierzycki C; Kedzia W; Nowak-Markwitz E; Spaczynski M; Zabel M; Podhorska-Okolow M; Dziegiel P
Int J Mol Sci; 2014 Dec; 15(12):23074-89. PubMed ID: 25514412
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
Treeck O; Haldar C; Ortmann O
Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.
Zemła A; Grzegorek I; Dzięgiel P; Jabłońska K
In Vivo; 2017; 31(5):801-809. PubMed ID: 28882945
[TBL] [Abstract][Full Text] [Related]
4. Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma.
Jablonska K; Pula B; Zemla A; Owczarek T; Wojnar A; Rys J; Ambicka A; Podhorska-Okolow M; Ugorski M; Dziegiel P
J Pineal Res; 2013 Apr; 54(3):334-45. PubMed ID: 23330677
[TBL] [Abstract][Full Text] [Related]
5. Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation.
Cucielo MS; Cesário RC; Silveira HS; Gaiotte LB; Dos Santos SAA; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889222
[TBL] [Abstract][Full Text] [Related]
6. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.
Carbajo-Pescador S; García-Palomo A; Martín-Renedo J; Piva M; González-Gallego J; Mauriz JL
J Pineal Res; 2011 Nov; 51(4):463-71. PubMed ID: 21718361
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
Lai L; Yuan L; Cheng Q; Dong C; Mao L; Hill SM
Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the melatonin receptor 1 in human colorectal adenocarcinomas.
Nemeth C; Humpeler S; Kallay E; Mesteri I; Svoboda M; Rögelsperger O; Klammer N; Thalhammer T; Ekmekcioglu C
J Biol Regul Homeost Agents; 2011; 25(4):531-42. PubMed ID: 22217986
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
10. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
[TBL] [Abstract][Full Text] [Related]
11. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
[TBL] [Abstract][Full Text] [Related]
12. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
Danielczyk K; Dziegiel P
Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985
[TBL] [Abstract][Full Text] [Related]
13. Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulation.
Kokkola T; Vaittinen M; Laitinen JT
J Pineal Res; 2007 Oct; 43(3):255-62. PubMed ID: 17803522
[TBL] [Abstract][Full Text] [Related]
14. Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line.
Watanabe M; Kobayashi Y; Takahashi N; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2008 Aug; 34(4):567-73. PubMed ID: 18937711
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
Girgert R; Hanf V; Emons G; Gründker C
Bioelectromagnetics; 2010 Apr; 31(3):237-45. PubMed ID: 19882681
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Expression of Melatonin Receptor MT1 and Glucose Transporter GLUT1 in Human Breast Cancer.
de Castro TB; Mota AL; Bordin-Junior NA; Neto DS; Zuccari DAPC
Anticancer Agents Med Chem; 2018; 18(15):2110-2116. PubMed ID: 30360728
[TBL] [Abstract][Full Text] [Related]
17. Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2.
Söderquist F; Hellström PM; Cunningham JL
PLoS One; 2015; 10(3):e0120195. PubMed ID: 25822611
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.
Bicer E; Bese T; Tuzun DD; Ilvan S; Kayan BO; Demirkiran F
Int J Gynecol Pathol; 2024 Mar; 43(2):190-199. PubMed ID: 37922887
[TBL] [Abstract][Full Text] [Related]
19. Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection.
Kaneko Y; Hayashi T; Yu S; Tajiri N; Bae EC; Solomita MA; Chheda SH; Weinbren NL; Parolini O; Borlongan CV
J Pineal Res; 2011 Apr; 50(3):272-80. PubMed ID: 21269327
[TBL] [Abstract][Full Text] [Related]
20. Melatonin and type 2 diabetes - a possible link?
Peschke E; Stumpf I; Bazwinsky I; Litvak L; Dralle H; Mühlbauer E
J Pineal Res; 2007 Apr; 42(4):350-8. PubMed ID: 17439551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
